§ 26-4-1. Short Title
This chapter shall be known and may be cited as the “Georgia Pharmacy Practice Act.” History. Code 1981, § 26-4-1 , enacted by Ga. L. 1998, p. 686, § 1.
§ 26-4-2. Liberal Construction of Chapter
The practice of pharmacy in this state is declared to be a learned profession and the practice of pharmacy affects the public health, safety, and welfare and is subject to regulation and control in the public interest. It is further declared to be a matter of public interest and concern that the practice of pharmacy […]
§ 26-4-3. Legislative Intent
It is the purpose of this chapter to promote, preserve, and protect the public health, safety, and welfare by and through the effective control and regulation of the practice of pharmacy; the licensure of pharmacists; the licensure, control, and regulation of all sites or persons, in or out of this state that distribute, manufacture, or […]
§ 26-4-4. Definition of “Practice of pharmacy.”
The “practice of pharmacy” means the interpretation, evaluation, or dispensing of prescription drug orders in the patient’s best interest; participation in drug and device selection, drug administration, drug regimen reviews, and drug or drug related research; provision of patient counseling and the provision of those acts or services necessary to provide pharmacy care; performing capillary […]
§ 26-4-5. Definitions
As used in this chapter, the term: “Administer” or “administration” means the provision of a unit dose of medication to an individual patient as a result of the order of an authorized practitioner of the healing arts. (1.05) “Authorized” means, in the case of a wholesale distributor, having a valid license pursuant to this chapter […]
§ 26-4-6. Provisions of Chapter Not Applicable to Facilities Engaged Solely in Distribution of Dialysate Drugs or Certain Dialysis Equipment Under Certain Conditions
The provisions of this chapter shall not apply to a facility engaged solely in the distribution of dialysate drugs, or devices necessary to perform home kidney dialysis to patients with end stage renal disease, provided that the following criteria are met: The dialysate drugs, or devices are approved or cleared by the federal Food and […]